228 related articles for article (PubMed ID: 15136745)
1. Arabidopsis thaliana DNA gyrase is targeted to chloroplasts and mitochondria.
Wall MK; Mitchenall LA; Maxwell A
Proc Natl Acad Sci U S A; 2004 May; 101(20):7821-6. PubMed ID: 15136745
[TBL] [Abstract][Full Text] [Related]
2. DNA Gyrase Is the Target for the Quinolone Drug Ciprofloxacin in Arabidopsis thaliana.
Evans-Roberts KM; Mitchenall LA; Wall MK; Leroux J; Mylne JS; Maxwell A
J Biol Chem; 2016 Feb; 291(7):3136-44. PubMed ID: 26663076
[TBL] [Abstract][Full Text] [Related]
3. Discoordinate gene expression of gyrA and gyrB in response to DNA gyrase inhibition in Escherichia coli.
Neumann S; Quiñones A
J Basic Microbiol; 1997; 37(1):53-69. PubMed ID: 9090126
[TBL] [Abstract][Full Text] [Related]
4. DNA gyrase is involved in chloroplast nucleoid partitioning.
Cho HS; Lee SS; Kim KD; Hwang I; Lim JS; Park YI; Pai HS
Plant Cell; 2004 Oct; 16(10):2665-82. PubMed ID: 15367714
[TBL] [Abstract][Full Text] [Related]
5. Dual Escherichia coli DNA Gyrase A and B Inhibitors with Antibacterial Activity.
Fois B; Skok Ž; Tomašič T; Ilaš J; Zidar N; Zega A; Peterlin Mašič L; Szili P; Draskovits G; Nyerges Á; Pál C; Kikelj D
ChemMedChem; 2020 Feb; 15(3):265-269. PubMed ID: 31721445
[TBL] [Abstract][Full Text] [Related]
6. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.
Fisher LM; Lawrence JM; Josty IC; Hopewell R; Margerrison EE; Cullen ME
Am J Med; 1989 Nov; 87(5A):2S-8S. PubMed ID: 2574005
[TBL] [Abstract][Full Text] [Related]
7. gyrB-225, a mutation of DNA gyrase that compensates for topoisomerase I deficiency: investigation of its low activity and quinolone hypersensitivity.
Heddle JG; Lu T; Zhao X; Drlica K; Maxwell A
J Mol Biol; 2001 Jun; 309(5):1219-31. PubMed ID: 11399091
[TBL] [Abstract][Full Text] [Related]
8. Arabidopsis thaliana GYRB3 does not encode a DNA gyrase subunit.
Evans-Roberts KM; Breuer C; Wall MK; Sugimoto-Shirasu K; Maxwell A
PLoS One; 2010 Mar; 5(3):e9899. PubMed ID: 20360860
[TBL] [Abstract][Full Text] [Related]
9. DNA gyrase from the albicidin producer Xanthomonas albilineans has multiple-antibiotic-resistance and unusual enzymatic properties.
Hashimi SM; Huang G; Maxwell A; Birch RG
Antimicrob Agents Chemother; 2008 Apr; 52(4):1382-90. PubMed ID: 18268084
[TBL] [Abstract][Full Text] [Related]
10. The acidic C-terminal tail of the GyrA subunit moderates the DNA supercoiling activity of Bacillus subtilis gyrase.
Lanz MA; Farhat M; Klostermeier D
J Biol Chem; 2014 May; 289(18):12275-85. PubMed ID: 24563461
[TBL] [Abstract][Full Text] [Related]
11. Fluoroquinolone-gyrase-DNA complexes: two modes of drug binding.
Mustaev A; Malik M; Zhao X; Kurepina N; Luan G; Oppegard LM; Hiasa H; Marks KR; Kerns RJ; Berger JM; Drlica K
J Biol Chem; 2014 May; 289(18):12300-12. PubMed ID: 24497635
[TBL] [Abstract][Full Text] [Related]
12. Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase.
Tran JH; Jacoby GA; Hooper DC
Antimicrob Agents Chemother; 2005 Jan; 49(1):118-25. PubMed ID: 15616284
[TBL] [Abstract][Full Text] [Related]
13. Active-site residues of Escherichia coli DNA gyrase required in coupling ATP hydrolysis to DNA supercoiling and amino acid substitutions leading to novobiocin resistance.
Gross CH; Parsons JD; Grossman TH; Charifson PS; Bellon S; Jernee J; Dwyer M; Chambers SP; Markland W; Botfield M; Raybuck SA
Antimicrob Agents Chemother; 2003 Mar; 47(3):1037-46. PubMed ID: 12604539
[TBL] [Abstract][Full Text] [Related]
14. Functions of a GyrBA fusion protein and its interaction with QnrB and quinolones.
Chen C; Villet R; Jacoby GA; Hooper DC
Antimicrob Agents Chemother; 2015 Nov; 59(11):7124-7. PubMed ID: 26324265
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms for defining supercoiling set point of DNA gyrase orthologs: I. A nonconserved acidic C-terminal tail modulates Escherichia coli gyrase activity.
Tretter EM; Berger JM
J Biol Chem; 2012 May; 287(22):18636-44. PubMed ID: 22457353
[TBL] [Abstract][Full Text] [Related]
16. Sequence analysis, purification, and study of inhibition by 4-quinolones of the DNA gyrase from Mycobacterium smegmatis.
Revel-Viravau V; Truong QC; Moreau N; Jarlier V; Sougakoff W
Antimicrob Agents Chemother; 1996 Sep; 40(9):2054-61. PubMed ID: 8878580
[TBL] [Abstract][Full Text] [Related]
17. Role of the extended alpha4 domain of Staphylococcus aureus gyrase A protein in determining low sensitivity to quinolones.
Strahilevitz J; Robicsek A; Hooper DC
Antimicrob Agents Chemother; 2006 Feb; 50(2):600-6. PubMed ID: 16436716
[TBL] [Abstract][Full Text] [Related]
18. Streptococcus pneumoniae DNA gyrase and topoisomerase IV: overexpression, purification, and differential inhibition by fluoroquinolones.
Pan XS; Fisher LM
Antimicrob Agents Chemother; 1999 May; 43(5):1129-36. PubMed ID: 10223925
[TBL] [Abstract][Full Text] [Related]
19. Distinct subunit architecture and assembly pattern of DNA gyrase from mycobacteria.
Faheem I; Gupta R; Nagaraja V
Mol Microbiol; 2023 Jun; 119(6):728-738. PubMed ID: 37190861
[TBL] [Abstract][Full Text] [Related]
20. Mutations reducing replication from R-loops suppress the defects of growth, chromosome segregation and DNA supercoiling in cells lacking topoisomerase I and RNase HI activity.
Usongo V; Martel M; Balleydier A; Drolet M
DNA Repair (Amst); 2016 Apr; 40():1-17. PubMed ID: 26947024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
